21 May 2009
Intestine as a source of growth factors and cytokines
D Porowski, M Niemczyk, J Ziółkowski, K Mucha, B Foroncewicz, M Pacholczyk, A Chmura, L PączekAnn Transplant 2009; 14(1): 37-37 :: ID: 880332
Abstract
Background: The activation status of immune system cells in the intestine is higher compared to analogous peripheral cells. The aim of the study was to assess the role of the human intestine in the production of growth factors and proinflammatory cytokines.
Material/Mathods: Twenty liver transplant recipients and 20 donors were included into study. The blood samples were collected from the artery supplying intestine, portal vein, and peripheral vein during liver harvesting (donors), or transplantation (recipients). ELISA method was used for assessment of serum levels of IL-6, TNF-alpha, TGF-beta, and HGF. Results. In the recipients, statistically lower levels of IL-6 in arterial blood were observed compared to portal blood (p<0.049). In the donors there were no statistically significant differences in IL-6 levels in the arterial and portal blood. No statistically significant differences in TNF-alpha, TGF-beta, and HGF levels between arterial and portal blood were observed in both groups.
Conclusions: healthy intestine is not a source of IL-6,TGF-beta, TNF-alpha, and HGF. However, in patients with liver cirrhosis intestine is a significant source of IL-6, but not others of the studied cytokines.
Keywords: Liver Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






